Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation

Science Translational Medicine(2023)10.1126/scitranslmed.adc9606Source: DataRank Database

Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation is a research paper published in Science Translational Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.96)OA: greenTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Emmett Fitzpatrick ORCID,Samuel Keeney ORCID,Alex d'Angelo ORCID,Benjamin B. Pressly,Michael T. Simpson ORCID

Live enrichment

PubMed:36599005 PMC:PMC9896655 OpenAlex:https://openalex.org/W4313544469

NCI NIH HHS

Grant: P30 CA013696

NHLBI NIH HHS

Grant: R01 HL131872

National Institutes of Health

Grant: 3P30CA013696-21S1

CANCER CENTER CORE SUPPORT GRANT

National Institutes of Health

Grant: 5R01HL131872-02

Serotonin Signaling in Mitral Valve Homeostasis, Maintenance and Restoration

FWCI

2.96

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

green

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9896655/pdf/nihms-1868461.pdf

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896655

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9896655/pdf/nihms-1868461.pdf

publisherhttps://www.science.org/doi/pdf/10.1126/scitranslmed.adc9606

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9896655

Fields of Study

Cardiac Valve Diseases and TreatmentsCardiovascular Function and Risk FactorsCardiac Fibrosis and RemodelingMedicine03 medical and health sciences0302 clinical medicineHumansAnimalsMiceMitral ValveMitral Valve InsufficiencyFluoxetineSerotonin Plasma Membrane Transport ProteinsSerotoninSelective Serotonin Reuptake Inhibitors

MeSH Terms

AnimalsFluoxetineHumansMitral ValveMitral Valve InsufficiencySerotoninSelective Serotonin Reuptake InhibitorsSerotonin Plasma Membrane Transport ProteinsMice

Keywords

Serotonin transporterSerotoninFluoxetineInternal medicineEndocrinologyReuptake inhibitorMedicinePopulationSerotonin Plasma Membrane Transport ProteinsBiologyReceptorMiceHumansAnimalsMitral ValveMitral Valve InsufficiencySelective Serotonin Reuptake Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation

FAIR Checklist

Authors (23)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)